Description: Pharmena S.A., a biotechnology company, manufactures and sells active ingredients in various areas of medicines in Poland and internationally. The company offers dermatological cosmetics, including skin, hair, and nail care products, as well as dietary supplement for atherosclerosis prophylaxis. It offers its products under the Menavitin, Dermena, Allerco, and Thermi names. The company is developing 1-MNA, an anti-atherosclerosis drug which is under phase II clinical trial. Pharmena S.A. was founded in 2002 and is based in Lódz, Poland. Pharmena S.A. is a subsidiary of Pelion S.A.
Home Page: www.pharmena.eu
ul. Wólczanska 178
Lódz,
90-530
Poland
Phone:
48 422 91 33 70
Officers
| Name | Title |
|---|---|
| Mr. Konrad Palka | Pres of Management Board, CEO & Pres |
| Ms. Marzena Wieczorkowska | VP of the Management Board and VP of R&D |
Exchange: WAR
Country: PL
Currency: Polish złoty (zł)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 1.2586 |
| Price-to-Sales TTM: | 4.2479 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 24 |